Harshita Katiyar - Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences

基本信息

浏览量：1

职业迁徙

个人简介

Hepatitis Virology

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluation of Serum Calprotectin As an Alternative Diagnostic Marker for Intrahepatic Cholestasis of Pregnancy

Harshita Katiyar,Sangeeta Yadav,Surender Singh, Ajay Kumar Mishra,Mandakini Pradhan,Raghavendra Lingaiah,Amit Goel

JOURNAL OF CLINICAL MEDICINEno. 18 (2024)

引用0浏览0WOS引用

Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India

Harshita Katiyar,Mrunal Kamat,Ameet K. Mandot,Amit Goel,Surender Singh, Ajay K. Mishra,Rajani Singh,Prachi Tiwari,Radha K. Dhiman,Samir Shah

Journal of clinical and experimental hepatologyno. 2 (2024): 101314-101314

引用0浏览0WOS引用

Seroprotection Achieved with Standard Four-Dose Schedule of Hepatitis B Vaccine in People with Chronic Kidney Disease: A Real-Life Data

Surender Singh, Ajay Kumar Mishra,Monika Yachha,Thakur Prashant Singh,Harshita Katiyar,Anupma Kaul,Radha Krishna Dhiman,Dharmendra Singh Bhadauria,Amit Goel

Indian Journal of Gastroenterologypp.1-7, (2024)

引用0浏览0WOS引用

Humoral and Cellular Immune Response in Patients of Liver Cirrhosis and Immunocompetent Recipient of ChAdOx1nCoV-19 Vaccine (Covishield)

Himanshu Dandu,Amit Goel,Manish Kumar,Hardeep Singh Malhotra,Harshita Katiyar, Monica Agarwal,Neeraj Kumar, Pragya Pandey, Shivani Rani,Geeta Yadav

CLINICAL AND EXPERIMENTAL MEDICINEno. 1 (2024)

引用0浏览0WOS引用

Eight Versus Twelve Weeks of Sofosbuvir-Velpatasvir in Treatment-Naïve Non-Cirrhotic Patients with Chronic Hepatitis C Virus Infection: Study Protocol for a Multicentric, Open Labelled, Randomized, Non-Inferiority Trial (RESOLVE Trial)

Ashish Awasthi,Harshita Katiyar,Sumit Rungta,Amar Deep,Vinod Kumar,Shalimar,Ajay Kumar,Prachi Tiwari,Amit Goel

PLOS ONEno. 5 (2023)

引用0浏览0WOS引用

Memory T-cell Targeted Immune Response in Patients of Liver Cirrhosis and Immunocompetent Recipient of ChAdOx1nCoV-19 Vaccine (Covishield)”

Geeta Yadav,Dandu Reddy,Amit Goel,Manish Kumar,Hardeep Malhotra,Harshita Katiyar, Monica Agarwal,Neeraj Kumar, Pragya Pandey, Shivani Rani

openalex（2023）

引用0浏览0引用

Rescue Use of Pegylated Interferon in Dialysis Patient Who Failed to Respond Sofosbuvir

Harshita Katiyar,Prachi Tiwari,Dharmendra S. Bhadauria,Praveer Rai,Amit Goel

INDIAN JOURNAL OF NEPHROLOGYno. 2 (2023)

引用0浏览0WOS引用

Sofosbuvir/Velpatasvir/Voxilaprevir for HCV Retreatment In Difficult To Treat Patients Who Failed With First-Line Direct Acting Antivirals: A Real-Life Data From India

Harshita Katiyar,Mrunal Kamat,Ameet kumar Mandot,Amit Goel,Surender Singh, Ajay Kumar Mishra,Rajani Singh,Radha Krishna Dhiman,Samir Shah

Journal of Clinical and Experimental Hepatology (2023): S93-S94

引用0浏览0引用

Sofosbuvir/Velpatasvir/Voxilaprevir for HCV Retreatment in Difficult to Treat Patients Who Failed with First-Line Direct Acting Antivirals: A Real-Life Data from India

Harshita Katiyar,Mrunal Kamat,Ameet Mandot,Amit Goel,Surender Singh, Ajay Kumar Mishra, Rohtas Singh,Radha K. Dhiman,Samir Shah

Journal of clinical and experimental hepatology (2023): S93-S94

引用0浏览0引用

Hepatitis C Re-Treatment with First Line Direct Acting Antiviral Drugs

Amit Goel,Harshita Katiyar, Mayank,Prachi Tiwari,Sumit Rungta,Abhai Verma,Amar Deep, Asari Sana,Praveer Rai,Rakesh Aggarwal

Journal of clinical and experimental hepatology（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn